Yifan Pharmaceutical Co Ltd
SZSE:002019
Yifan Pharmaceutical Co Ltd
Net Income (Common)
Yifan Pharmaceutical Co Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Y
|
Yifan Pharmaceutical Co Ltd
SZSE:002019
|
Net Income (Common)
¥134.9m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
41%
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Net Income (Common)
¥5.9B
|
CAGR 3-Years
4%
|
CAGR 5-Years
14%
|
CAGR 10-Years
23%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Net Income (Common)
¥3.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Net Income (Common)
¥2.8B
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
21%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Net Income (Common)
¥4.2B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
2%
|
CAGR 10-Years
13%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Net Income (Common)
¥4.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
See Also
What is Yifan Pharmaceutical Co Ltd's Net Income (Common)?
Net Income (Common)
134.9m
CNY
Based on the financial report for Sep 30, 2023, Yifan Pharmaceutical Co Ltd's Net Income (Common) amounts to 134.9m CNY.
What is Yifan Pharmaceutical Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
41%
Over the last year, the Net Income (Common) growth was -29%. The average annual Net Income (Common) growth rates for Yifan Pharmaceutical Co Ltd have been -50% over the past three years , -35% over the past five years , and 41% over the past ten years .